Skip Nav Destination
Issues
1 September 2017
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Highlights
Commentary
Reviews
The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium
Hazel B. Nichols; Minouk J. Schoemaker; Lauren B. Wright; Craig McGowan; Mark N. Brook; Kathleen M. McClain; Michael E. Jones; Hans-Olov Adami; Claudia Agnoli; Laura Baglietto; Leslie Bernstein; Kimberly A. Bertrand; William J. Blot; Marie-Christine Boutron-Ruault; Lesley Butler; Yu Chen; Michele M. Doody; Laure Dossus; A. Heather Eliassen; Graham G. Giles; Inger T. Gram; Susan E. Hankinson; Judy Hoffman-Bolton; Rudolf Kaaks; Timothy J. Key; Victoria A. Kirsh; Cari M. Kitahara; Woon-Puay Koh; Susanna C. Larsson; Eiliv Lund; Huiyan Ma; Melissa A. Merritt; Roger L. Milne; Carmen Navarro; Kim Overvad; Kotaro Ozasa; Julie R. Palmer; Petra H. Peeters; Elio Riboli; Thomas E. Rohan; Atsuko Sadakane; Malin Sund; Rulla M. Tamimi; Antonia Trichopoulou; Lars Vatten; Kala Visvanathan; Elisabete Weiderpass; Walter C. Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Dale P. Sandler; Anthony J. Swerdlow
Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
Chirag J. Patel; Jacqueline Kerr; Duncan C. Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R. Karagas; Kimberly A. McAllister; Leah E. Mechanic; M. Daniele Fallin; Christine Ladd-Acosta; Ian A. Blair; Susan L. Teitelbaum; Christopher I. Amos
Research Articles
Quantifying the Genetic Correlation between Multiple Cancer Types
Sara Lindström; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Hilary Finucane; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Brendan Bulik-Sullivan; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Fredrick R. Schumacher; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Christopher I. Amos; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rayjean J. Hung; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Kristin Rand; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Stephen B. Gruber; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; David Conti; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jennifer B. Permuth; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Hui-Yi Lin; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Ellen L. Goode; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Thomas A. Sellers; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Laufey T. Amundadottir; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rachael Stolzenberg-Solomon; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Alison Klein; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Gloria Petersen; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Harvey Risch; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Brian Wolpin; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Li Hsu; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jeroen R. Huyghe; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jenny Chang-Claude; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Andrew Chan; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Sonja Berndt; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rosalind Eeles; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Douglas Easton; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Christopher A. Haiman; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; David J. Hunter; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Benjamin Neale; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Alkes L. Price; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Peter Kraft; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO
Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes
Xiang Shu; Mark P. Purdue; Yuanqing Ye; Huakang Tu; Christopher G. Wood; Nizar M. Tannir; Zhaoming Wang; Demetrius Albanes; Susan M. Gapstur; Victoria L. Stevens; Nathaniel Rothman; Stephen J. Chanock; Xifeng Wu
Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women
Stacey E. Alexeeff; Nnaemeka U. Odo; Jafi A. Lipson; Ninah Achacoso; Joseph H. Rothstein; Martin J. Yaffe; Rhea Y. Liang; Luana Acton; Valerie McGuire; Alice S. Whittemore; Daniel L. Rubin; Weiva Sieh; Laurel A. Habel
Null Results in Brief
Author Choice
Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study
John Charles A. Lacson; Huiyan Ma; Eunjung Lee; Susan L. Neuhausen; Hoda Anton-Culver; Peggy Reynolds; David O. Nelson; Argyrios Ziogas; David Van Den Berg; Dennis M. Deapen; Leslie Bernstein; Fredrick R. Schumacher
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
Albina N. Minlikeeva; on behalf of the Ovarian Cancer Association Consortium; Jo L. Freudenheim; on behalf of the Ovarian Cancer Association Consortium; Kevin H. Eng; on behalf of the Ovarian Cancer Association Consortium; Rikki A. Cannioto; on behalf of the Ovarian Cancer Association Consortium; Grace Friel; on behalf of the Ovarian Cancer Association Consortium; J. Brian Szender; on behalf of the Ovarian Cancer Association Consortium; Brahm Segal; on behalf of the Ovarian Cancer Association Consortium; Kunle Odunsi; on behalf of the Ovarian Cancer Association Consortium; Paul Mayor; on behalf of the Ovarian Cancer Association Consortium; Brenda Diergaarde; on behalf of the Ovarian Cancer Association Consortium; Emese Zsiros; on behalf of the Ovarian Cancer Association Consortium; Linda E. Kelemen; on behalf of the Ovarian Cancer Association Consortium; Martin Köbel; on behalf of the Ovarian Cancer Association Consortium; Helen Steed; on behalf of the Ovarian Cancer Association Consortium; Anna deFazio; on behalf of the Australian Ovarian Cancer Study Group; on behalf of the Ovarian Cancer Association Consortium; Susan J. Jordan; on behalf of the Ovarian Cancer Association Consortium; Peter A. Fasching; on behalf of the Ovarian Cancer Association Consortium; Matthias W. Beckmann; on behalf of the Ovarian Cancer Association Consortium; Harvey A. Risch; on behalf of the Ovarian Cancer Association Consortium; Mary Anne Rossing; on behalf of the Ovarian Cancer Association Consortium; Jennifer A. Doherty; on behalf of the Ovarian Cancer Association Consortium; Jenny Chang-Claude; on behalf of the Ovarian Cancer Association Consortium; Marc T. Goodman; on behalf of the Ovarian Cancer Association Consortium; Thilo Dörk; on behalf of the Ovarian Cancer Association Consortium; Robert Edwards; on behalf of the Ovarian Cancer Association Consortium; Francesmary Modugno; on behalf of the Ovarian Cancer Association Consortium; Roberta B. Ness; on behalf of the Ovarian Cancer Association Consortium; Keitaro Matsuo; on behalf of the Ovarian Cancer Association Consortium; Mika Mizuno; on behalf of the Ovarian Cancer Association Consortium; Beth Y. Karlan; on behalf of the Ovarian Cancer Association Consortium; Ellen L. Goode; on behalf of the Ovarian Cancer Association Consortium; Susanne K. Kjær; on behalf of the Ovarian Cancer Association Consortium; Estrid Høgdall; on behalf of the Ovarian Cancer Association Consortium; Joellen M. Schildkraut; on behalf of the Ovarian Cancer Association Consortium; Kathryn L. Terry; on behalf of the Ovarian Cancer Association Consortium; Daniel W. Cramer; on behalf of the Ovarian Cancer Association Consortium; Elisa V. Bandera; on behalf of the Ovarian Cancer Association Consortium; Lisa E. Paddock; on behalf of the Ovarian Cancer Association Consortium; Lambertus A. Kiemeney; on behalf of the Ovarian Cancer Association Consortium; Leon F.A.G. Massuger; on behalf of the Ovarian Cancer Association Consortium; Rebecca Sutphen; on behalf of the Ovarian Cancer Association Consortium; Hoda Anton-Culver; on behalf of the Ovarian Cancer Association Consortium; Argyrios Ziogas; on behalf of the Ovarian Cancer Association Consortium; Usha Menon; on behalf of the Ovarian Cancer Association Consortium; Simon A. Gayther; on behalf of the Ovarian Cancer Association Consortium; Susan J. Ramus; on behalf of the Ovarian Cancer Association Consortium; Aleksandra Gentry-Maharaj; on behalf of the Ovarian Cancer Association Consortium; Celeste L. Pearce; on behalf of the Ovarian Cancer Association Consortium; Anna H. Wu; on behalf of the Ovarian Cancer Association Consortium; Jolanta Kupryjanczyk; on behalf of the Ovarian Cancer Association Consortium; Allan Jensen; on behalf of the Ovarian Cancer Association Consortium; Penelope M. Webb; on behalf of the Ovarian Cancer Association Consortium; Kirsten B. Moysich; on behalf of the Ovarian Cancer Association Consortium
Letter to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.